15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $7M | $23M | 99.6% | -105.8% | 322.8% | 115.3% | -$7M | $892488 | — |
| 2024 | $7M | $9M | 99.8% | -101.5% | 71.9% | 19.6% | -$3M | $7M | — |
| 2023 | $3M | $8M | 0.0% | -224.0% | 899.9% | 43.4% | -$5M | — | — |
| 2022 | — | -$11M | — | — | 1114.2% | -293.6% | -$7M | — | — |
| 2021 | — | -$7M | — | — | -91.0% | -66.6% | -$6M | — | $6M |
| 2020 | $1M | -$8M | 91.4% | -531.7% | -145.3% | -76.2% | -$5M | — | $10M |
| 2019 | $1M | -$2M | 90.6% | -120.8% | 58.4% | -120.7% | $1M | — | $1M |
| 2018 | $494375 | -$3M | 81.7% | -532.8% | 112.9% | -395.7% | -$672371 | — | $212243 |
| 2017 | $282145 | -$702163 | 81.6% | -227.0% | 14.1% | -263.6% | -$181270 | — | $25759 |
| 2017 | — | $18M | — | — | -385.1% | 9335.8% | — | — | $39649 |
| 2016 | $50901 | -$2M | 70.3% | -4146.1% | 46.0% | -742.2% | -$339600 | — | $152404 |
| 2015 | $11689 | -$5M | 33.2% | -5090.9% | 132.0% | -855.4% | -$151622 | — | $492004 |
| 2014 | $16588 | -$2M | 53.7% | -10131.3% | 39.7% | -1603.4% | — | — | $18626 |
| 2013 | $27063 | -$760679 | 60.9% | -2236.4% | 19.9% | -620.7% | — | — | $18027 |
| 2012 | $56377 | -$666454 | 63.0% | -979.7% | 19.8% | -532.0% | — | — | $7194 |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $2M | $888740 | 97.2% | -59.3% | 5.4% | 3.4% | — | $2M | — |
| Mar '26 | $2M | -$6M | 99.7% | -78.9% | -36.9% | -22.5% | — | $2M | — |
| Dec '25 | $2M | $2M | 0.0% | -89.2% | 27.8% | 9.9% | $13384 | $892488 | — |
| Sep '25 | $2M | -$3M | 0.0% | -93.1% | -58.4% | -18.0% | -$2M | $2M | — |
| Jun '25 | $2M | -$4M | 99.8% | -160.4% | 50.6% | -18.7% | -$2M | $5M | — |
| Mar '25 | $2M | -$17M | 99.8% | -73.3% | 64.0% | -54.8% | -$4M | — | — |
| Dec '24 | $2M | -$4M | 0.0% | -116.6% | -30.1% | -8.2% | -$696253 | $7M | — |
| Sep '24 | $1M | -$2M | 0.0% | -90.7% | 6993.7% | -9.6% | -$640807 | — | — |
| Jun '24 | $2M | -$2M | 0.0% | -100.9% | -164.7% | -12.6% | -$2M | — | — |
| Mar '24 | $2M | -$2M | 0.0% | -95.7% | -15721.4% | -9.2% | -$310255 | — | — |
| Dec '23 | — | -$2M | — | — | -223.4% | -10.8% | -$789883 | — | — |
| Sep '23 | — | -$1M | — | — | -334.9% | -7.3% | -$1M | — | — |
| Jun '23 | — | -$2M | — | — | 131.4% | -45.8% | — | — | — |
| Mar '23 | — | -$3M | — | — | -2883.5% | -41.5% | — | — | — |
| Dec '22 | — | -$3M | — | — | 283.0% | -74.6% | -$1M | — | — |
| Sep '22 | — | -$3M | — | — | -198.1% | -59.8% | -$2M | — | — |
| Jun '22 | — | -$3M | — | — | -83.5% | -46.8% | -$2M | — | $2M |
| Mar '22 | — | -$3M | — | — | -49.6% | -34.4% | -$2M | — | $4M |
| Dec '21 | — | -$141525 | — | — | -1.9% | -1.4% | -$1M | — | $6M |
| Sep '21 | — | -$2M | — | — | — | -28.9% | — | — | $5M |
How the market has priced IVF against its own fundamentals since 2025-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, INVO Fertility, Inc.'s revenue has grown 45.8% per year. These are computed facts, not advice.
As of FY2025, INVO Fertility, Inc. reported $892488 of total debt against — of cash; operating income covered interest expense -5.6×.
In FY2025, gross margin was 99.6%, operating margin -105.8%, and net margin 340.9%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.